Health Report - Separate Stories Podcast

A study yet to be peer-reviewed has assessed the evidence on treating COVID-19 with antibody infusions—particularly monoclonal antibodies. It has found that in the early days of the pandemic doses were too high—but things are different with Omicron and its variants, because the antibodies target different sections of the virus.